REGENERON PHARMACEUTICALS INC earnings per share and revenue

RGO earnings per share for the last quarter are 10.56 CHF whereas the estimation was 9.91 CHF which accounts for 6.54% surprise. Company revenue for the same period amounts to 3.15 B CHF despite the estimated figure of 3.11 B CHF. Estimated earnings per share for the next quarter are 9.81 CHF, and revenue is expected to reach 3.32 B CHF. Also watch annual changes over time to get a bigger picture of RGO earnings per share and revenue dynamics.